What would you do if all of a sudden you had to have those resources there and you do not have adequate resources to carry out the mission as you see it now?

Do you see the fact that they have domestic problems there as also contributing to the problem that we are having over there?

Right now, I can name a lot of places in Africa that I personally looked at and I could see problems coming.

What we are trying to do here, ma'am, is we want to make sure that the tax dollars are being used for their intended purpose.

if it is going to continue the way that it is going, then there is no way I am going to be able to support reauthorization.

Mr. President, I ask unanimous consent that the Senate be in a period of morning business, with Senators permitted to speak therein for up to 10 minutes each. The PRESIDING OFFICER. Is there objection? Without objection, it is so ordered…

So the 45 minutes is not just completing the form. It is gathering information.

I appreciate the optimism of the administration. But I just--I don't see it.

The Cancer Moonshot, we were all out at NIH, or a number of us, earlier this week to discuss that.

We are going to have some sort of fiscal cliff then 2 years down the road.

You know, duct tape is not a viable IT strategy, and all too frequently that is what we are at.

It places significant limitations on when drug screening and testing can occur, all but ensuring that the law will not be implemented as intended.

I have people in this study that are terminal, and that you are allowing the study to be able to go through, to the end, when you see an obvious effect.

When the first level is done and patients hear the stories--or people that are not patients hear the stories--this seems to be effective, but then there is the pause to say, 'We are going to go through multiple other areas.'

But only $2 billion in disbursements.

There is a difference between effective and duplicative.

As you are aware, as I mentioned in my opening remarks, most of the initiatives you are proposing are not within our jurisdiction.

I am concerned that the FDA has a requirement and that they are trying to fulfill that requirement to be able to get the drug to market, but that it may inadvertently doom some child or some adult to be stuck in a situation where they are…